In colorectal cancer, the copy number of BORIS is amplified and BORIS is aberrantly expressed6, 9, 14, suggesting the potential clinical significance of BORIS in the diagnosis/treatment of colorectal cancer. The gene discussed is CTCFL; the disease is colorectal cancer.